Key clinical point: Surgical site infections are most common after revision vs. primary total joint replacement.
Major finding: The 90-day risk of surgical site infection was 5.77 times higher after revision vs. primary total joint replacement.
Study details: Retrospective observational cohort study of 335,134 total knee replacements and 163,547 total hip replacements.
Disclosures: Johnson & Johnson Medical Device Companies provided funding. Three coinvestigators reported employment and stockholder ties to the company. Dr. Edmiston and one coinvestigator reported speaker fees for Ethicon, a Johnson & Johnson company.
Edmiston CE et al. Am J Infect Control. 2019 May 6. doi: 10.1016/j.ajic.2019.03.030.
This Week's Must Reads
Must Reads in Healthcare-acquired Infections
Antibiotic Use and Hospital Onset CDI Infection, Clin Infect Dis; ePub 2019 Mar 1; Kazakova, et al